Key result
While blood pressure responses to angiotensin I infusion did not differ between ACE genotypes II and DD, genotype II showed a greater decrease in heart rate.
Why the study?
Does ACE genotype (DD vs II) affect pressor and hormonal responses to angiotensin I infusion in healthy men?
Observational (n=16)
Does ACE genotype (DD vs II) affect pressor and hormonal responses to angiotensin I infusion in healthy men?
ACE genotype (DD vs II) does not significantly alter pressor or hormonal responses to acute angiotensin I infusion in healthy men, though it may affect chronotropic responses.
Answers are grounded in this paper and cite their sources.
ACE I/D genotype does not alter pressor responses; leaves open potential chronotropic effects in healthy men.
The effects of incremental infusion of angiotensin I on pressor and hormonal responses in relation to the angiotensin-converting enzyme (ACE) genotype were compared in healthy men of genotype DD (n = 8) and II (n = 8). The R(d)25 was the rate of angiotensin I infusion required to achieve a 25-mm Hg increase in diastolic pressure, and the R(s)25, that which caused a 25-mm Hg increase in systolic pressure. Changes in heart rate (HR25) were analysed at the time the R(d)25 was achieved. Serum ACE activity and plasma renin, angiotensin II, and aldosterone concentrations were measured at the start and end of the angiotensin I infusion. Serum ACE activity differed significantly between the genotypes with significantly higher mean values in DD subjects (46.3 +/- SEM 5.2 U/L) than II subjects (12.3 +/- 1.4 U/L; p < 0.001). Age, weight, and baseline blood pressure, heart rate, urinary sodium excretion, plasma renin, angiotensin II, and aldosterone concentrations did not differ between genotypes. The geometric mean infusion rates of angiotensin I required to achieve R(d)25 were 2.53 micrograms/min in II subjects and 2.67 micrograms/min in DD subjects (ratio of infusion rates, 0.95; 95% CI, 0.44-2.02; p > 0.05). The corresponding infusion rates for systolic blood pressure (R(s)25) were 4.47 micrograms/min in II subjects and 3.39 micrograms/min in DD subjects (ratio, 1.32; 95% CI, 0.49-3.55; p > 0.05). At the time of R(d)25, changes in heart rate from baseline were +1.2 beats/min for DD subjects and -9.5 beats/min for II subjects (diff II-DD = 10.7 beats/min; 95% CI, 6.7-14.8; p = 0.01). There were no differences in plasma renin, angiotensin, and aldosterone responses to angiotensin I infusion between the DD and II genotypes. We showed no difference in blood pressure or renin-angiotensin-aldosterone system responses to infusion of angiotensin I related to the deletion or insertion allele of the ACE gene polymorphism, but the study has insufficient power to exclude with certainty such differences. There was a significant difference between II and DD subjects in the chronotropic response to angiotensin I infusion.
No takes yet. Share an insight, caveat, or question.
Chadwick et al. (1997) conducted an observational in Healthy (n=16). ACE genotype II vs. ACE genotype DD was evaluated on Rate of angiotensin I infusion required to achieve a 25-mm Hg increase in diastolic pressure (R(d)25) (ratio 0.95, 95% CI 0.44-2.02, p=> 0.05). While blood pressure responses to angiotensin I infusion did not differ between ACE genotypes II and DD, genotype II showed a greater decrease in heart rate.
Synapse has enriched 10 related papers. Consider them for comparative context: